NewsMarkets

Science

Study Links Microglial Dysfunction to Fragile X Syndrome via Lysosomal Impairment

Research published in Molecular Psychiatry identifies impaired FMRP-regulated lysosomal function in microglia as a key mechanism underlying fragile X syndrome.

1 publisher · 1 article · first seen 17 Oct 2026 · updated 21d ago

Headline and summary written by an AI model from the linked article; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

1 publisher has covered this in 1 article since 17 Oct 2026. Molecular Psychiatry published first, on 17 October at 00:00 UTC.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. A microglial basis for fragile X syndrome via impairment of FMRP-regulated lysosomal function Molecular Psychiatry ·
Embed this story

Paste this into any web page to show the live odds, with a link back here.